COMMUNIQUÉS West-GlobeNewswire

IHA Recognizes California Provider Organizations for Healthcare Performance
05/12/2024
The Integrated Healthcare Association’s Align. Measure. Perform. program honors top-performing and most-improved provider organizations OAKLAND, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- The Integrated Healthcare [...]
PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024
05/12/2024
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com Date Total of shares [...]
PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024
05/12/2024
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 – Symbole : PHXM) Site web : www.phaxiam.com Date Nombre total d’ [...]
Acentra Health’s Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization
05/12/2024
Consecutive accreditations from URAC spanning 24 years underscore the company’s unwavering compliance with rigorous standards for independent medical reviews MCLEAN, Va., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Acentra Health [...]
New generation steps up to continue IBA’s entrepreneurial ownership
05/12/2024
Louvain-la-Neuve, Belgium, 5 December 2024 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, announces today an initiative aimed at perpetuating the entrepreneurial anchoring of its [...]
La nouvelle génération s’engage pour perpétuer l’ancrage entrepreneurial d’IBA
05/12/2024
Louvain-la-Neuve, Belgique, le 5 décembre 2024 - IBA (Ion Beam Applications SA), le leader mondial de la technologie des accélérateurs de particules, annonce aujourd'hui une initiative visant à pérenniser l’ancrage [...]
Wugen to Present Clinical Data at the 2024 ASH Annual Meeting Ahead of Pivotal Trial Launch of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
05/12/2024
Data Support Start of First Pivotal Trial for an Off-the-Shelf, Allogeneic CD7-Targeted CAR-T Cell Therapy in Pediatric and Adult Patients ST. LOUIS and SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Wugen, Inc., a [...]
Coloplast A/S - Decisions at the Annual General Meeting 2024
05/12/2024
Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2023/24 was approved. Distribution of year-end dividend of [...]
Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame
05/12/2024
WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi , CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, [...]
Unlock the Secrets to Healthy Aging: BioAro Unveils $199 Epigenetic Test at UAE Longevity Fitness Challenge
05/12/2024
Measure your biological age with cutting-edge epigenetic testing, 85% more affordable than competitors, bringing advanced longevity science within reach for all NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Are you aging [...]
HD Nursing to Showcase Advances in Fall Risk Prediction at IHI Forum 2024
05/12/2024
BENTON, Ark., Dec. 05, 2024 (GLOBE NEWSWIRE) -- HD Nursing , the leading patient safety solution that combines predictive analytics with individualized fall and pressure injury prevention, is proud to announce its [...]
Sharps Technology’s CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue
05/12/2024
Shareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing expansion, and expected delivery schedule Initial production and [...]
Lungpacer Medical Announces Premarket Approval for AeroPace® System
05/12/2024
AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy for quicker patient liberation from mechanical ventilation EXTON, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Lungpacer Medical, a [...]
Aionics Unveils Expansion into Aviation Batteries Fueled by Strategic Investments and Industry Partnerships
05/12/2024
Company will leverage recent financing and joint development agreement with electric aviation manufacturing partner to develop safer and more efficient batteries with its AI-powered electrolyte design platform PALO ALTO [...]
Vanqua Bio to Present Pre-Clinical Data on VQ-201, a Next Generation C5aR1 Antagonist for the Treatment of Inflammatory Disorders
05/12/2024
CHICAGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Vanqua Bio , a clinical-stage biopharmaceutical company, announced that the company will present at the 8th Annual Complement-Based Drug Development Summit , which will be held [...]
Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
05/12/2024
Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that [...]
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
05/12/2024
Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISS Collaboration Aims to Enhance Healthspan on Earth and Improve Astronaut Health in Space IM8, a new premium supplements brand launched officially on [...]
Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group
05/12/2024
Pooled data analysis of efficacy and safety from Phase 2b and Phase 3 data sets in patients with early-stage Parkinson’s disease (PD) support P2B001 as a first line, once-daily treatment choice for early PD KIRYAT ONO, [...]
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025
05/12/2024
First-in-class catheter-based sensing technology designed to sense neuronal signals that indicate pain or disease and destroy those nerves at the source Company expects to submit an Investigational Device Exemption (“ [...]

Pages